 Arleta Rewers
Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Ketoacidosis | 36 | 2023 | 159 | 8.070 |
Why?
| | Diabetes Mellitus, Type 1 | 24 | 2023 | 3245 | 1.720 |
Why?
| | Fluid Therapy | 11 | 2023 | 121 | 1.550 |
Why?
| | Hypoglycemia | 7 | 2020 | 385 | 0.850 |
Why?
| | Diabetes Mellitus | 7 | 2023 | 906 | 0.830 |
Why?
| | Acidosis | 1 | 2021 | 87 | 0.710 |
Why?
| | Child | 41 | 2023 | 18407 | 0.670 |
Why?
| | Insulin | 8 | 2018 | 2082 | 0.630 |
Why?
| | Adolescent | 31 | 2023 | 17862 | 0.550 |
Why?
| | Blood Glucose | 6 | 2023 | 1821 | 0.490 |
Why?
| | Hyperglycemic Hyperosmolar Nonketotic Coma | 3 | 2022 | 5 | 0.480 |
Why?
| | Child, Preschool | 19 | 2023 | 9093 | 0.440 |
Why?
| | Hypoglycemic Agents | 5 | 2022 | 1006 | 0.390 |
Why?
| | Hospitalization | 3 | 2016 | 1754 | 0.390 |
Why?
| | Colorado | 7 | 2021 | 4089 | 0.370 |
Why?
| | Sodium | 2 | 2021 | 183 | 0.360 |
Why?
| | Infant | 15 | 2023 | 7945 | 0.350 |
Why?
| | Diabetic Nephropathies | 2 | 2022 | 234 | 0.320 |
Why?
| | Quality Improvement | 1 | 2016 | 953 | 0.320 |
Why?
| | Humans | 44 | 2023 | 115038 | 0.300 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2006 | 14 | 0.280 |
Why?
| | Bicarbonates | 2 | 2017 | 41 | 0.280 |
Why?
| | Hydrogen-Ion Concentration | 5 | 2017 | 512 | 0.260 |
Why?
| | Brain Injuries | 2 | 2022 | 452 | 0.250 |
Why?
| | Socioeconomic Factors | 4 | 2017 | 1081 | 0.250 |
Why?
| | Point-of-Care Systems | 1 | 2006 | 139 | 0.250 |
Why?
| | Glasgow Coma Scale | 3 | 2021 | 144 | 0.250 |
Why?
| | Severity of Illness Index | 8 | 2021 | 2551 | 0.250 |
Why?
| | Male | 25 | 2022 | 55729 | 0.240 |
Why?
| | Femoral Fractures | 1 | 2005 | 67 | 0.240 |
Why?
| | Acute Kidney Injury | 2 | 2021 | 638 | 0.240 |
Why?
| | Multiple Trauma | 1 | 2005 | 90 | 0.240 |
Why?
| | Female | 25 | 2022 | 59610 | 0.230 |
Why?
| | Hypertension | 2 | 2023 | 1058 | 0.220 |
Why?
| | Electrolytes | 2 | 2021 | 55 | 0.210 |
Why?
| | Prevalence | 4 | 2022 | 2255 | 0.210 |
Why?
| | Risk Factors | 9 | 2022 | 8642 | 0.200 |
Why?
| | White Matter | 1 | 2023 | 104 | 0.200 |
Why?
| | Neurocognitive Disorders | 1 | 2020 | 23 | 0.190 |
Why?
| | Kidney Tubules | 1 | 2021 | 107 | 0.180 |
Why?
| | Communicable Disease Control | 1 | 2021 | 67 | 0.180 |
Why?
| | Brain Edema | 3 | 2018 | 60 | 0.180 |
Why?
| | Emergencies | 1 | 2020 | 147 | 0.160 |
Why?
| | Incidence | 4 | 2015 | 2318 | 0.160 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 273 | 0.160 |
Why?
| | Rehydration Solutions | 1 | 2018 | 7 | 0.160 |
Why?
| | Logistic Models | 3 | 2015 | 1839 | 0.150 |
Why?
| | Emergency Service, Hospital | 4 | 2020 | 1811 | 0.150 |
Why?
| | Endocrinology | 1 | 2018 | 69 | 0.150 |
Why?
| | Pediatrics | 3 | 2018 | 981 | 0.140 |
Why?
| | Cognition | 2 | 2023 | 983 | 0.140 |
Why?
| | Pediatric Obesity | 1 | 2023 | 492 | 0.140 |
Why?
| | Length of Stay | 2 | 2016 | 950 | 0.140 |
Why?
| | Pandemics | 2 | 2022 | 1321 | 0.140 |
Why?
| | Treatment Outcome | 3 | 2016 | 9122 | 0.130 |
Why?
| | Tertiary Care Centers | 1 | 2016 | 126 | 0.130 |
Why?
| | Matrix Metalloproteinases | 1 | 2016 | 89 | 0.120 |
Why?
| | Prospective Studies | 5 | 2021 | 6232 | 0.120 |
Why?
| | Hyperglycemia | 2 | 2020 | 293 | 0.120 |
Why?
| | Insulin Infusion Systems | 1 | 2017 | 296 | 0.120 |
Why?
| | Blood Pressure | 1 | 2020 | 1539 | 0.110 |
Why?
| | Infant, Newborn | 4 | 2019 | 5040 | 0.110 |
Why?
| | United States | 5 | 2020 | 12224 | 0.110 |
Why?
| | Hospitals, Pediatric | 1 | 2016 | 477 | 0.110 |
Why?
| | Adolescent Development | 1 | 2013 | 84 | 0.100 |
Why?
| | Follow-Up Studies | 2 | 2018 | 4420 | 0.100 |
Why?
| | Prognosis | 3 | 2020 | 3334 | 0.100 |
Why?
| | Combined Modality Therapy | 2 | 2014 | 1127 | 0.090 |
Why?
| | Precision Medicine | 1 | 2014 | 340 | 0.090 |
Why?
| | Longitudinal Studies | 1 | 2017 | 2389 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2014 | 2098 | 0.090 |
Why?
| | Patient Transfer | 1 | 2012 | 143 | 0.090 |
Why?
| | Cohort Studies | 4 | 2023 | 4904 | 0.090 |
Why?
| | Infusions, Intravenous | 2 | 2023 | 372 | 0.090 |
Why?
| | Biomarkers | 2 | 2021 | 3419 | 0.090 |
Why?
| | Blood Urea Nitrogen | 3 | 2022 | 51 | 0.090 |
Why?
| | Triage | 1 | 2012 | 192 | 0.090 |
Why?
| | Evidence-Based Medicine | 1 | 2014 | 676 | 0.090 |
Why?
| | Emergency Medical Services | 2 | 2018 | 587 | 0.090 |
Why?
| | Blood Chemical Analysis | 1 | 2010 | 90 | 0.080 |
Why?
| | Sodium Chloride | 2 | 2021 | 136 | 0.080 |
Why?
| | Glomerular Filtration Rate | 2 | 2023 | 604 | 0.080 |
Why?
| | Child Development | 1 | 2013 | 389 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1398 | 0.080 |
Why?
| | Amylases | 1 | 2008 | 14 | 0.080 |
Why?
| | Consensus | 2 | 2022 | 534 | 0.080 |
Why?
| | Lipase | 1 | 2008 | 57 | 0.080 |
Why?
| | Monitoring, Physiologic | 1 | 2010 | 249 | 0.070 |
Why?
| | Retrospective Studies | 4 | 2023 | 12547 | 0.070 |
Why?
| | Dehydration | 2 | 2023 | 40 | 0.070 |
Why?
| | Electrochemistry | 1 | 2006 | 78 | 0.070 |
Why?
| | Drug Administration Schedule | 2 | 2018 | 719 | 0.070 |
Why?
| | Educational Status | 1 | 2008 | 412 | 0.070 |
Why?
| | Insurance, Health | 1 | 2008 | 244 | 0.070 |
Why?
| | Survival Rate | 1 | 2010 | 1646 | 0.060 |
Why?
| | Small-Area Analysis | 1 | 2005 | 8 | 0.060 |
Why?
| | Abbreviated Injury Scale | 1 | 2005 | 21 | 0.060 |
Why?
| | Models, Biological | 1 | 2012 | 1636 | 0.060 |
Why?
| | Wounds and Injuries | 1 | 2012 | 723 | 0.060 |
Why?
| | Diagnosis, Differential | 3 | 2018 | 1355 | 0.060 |
Why?
| | Medically Uninsured | 1 | 2005 | 121 | 0.060 |
Why?
| | International Classification of Diseases | 1 | 2005 | 116 | 0.060 |
Why?
| | Creatine | 1 | 2023 | 50 | 0.050 |
Why?
| | Aspartic Acid | 1 | 2023 | 78 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2008 | 1435 | 0.050 |
Why?
| | Choline | 1 | 2023 | 108 | 0.050 |
Why?
| | Threonine | 1 | 2022 | 40 | 0.050 |
Why?
| | Histidine | 1 | 2022 | 57 | 0.050 |
Why?
| | Electrocardiography | 1 | 2005 | 562 | 0.050 |
Why?
| | Emergency Medicine | 1 | 2005 | 220 | 0.050 |
Why?
| | Heart Diseases | 1 | 2005 | 330 | 0.050 |
Why?
| | Leucine | 1 | 2022 | 107 | 0.050 |
Why?
| | Glycopeptides | 1 | 2021 | 43 | 0.050 |
Why?
| | Tryptophan | 1 | 2022 | 135 | 0.050 |
Why?
| | Registries | 2 | 2022 | 1763 | 0.050 |
Why?
| | Intelligence Tests | 1 | 2020 | 59 | 0.050 |
Why?
| | Chlorides | 1 | 2021 | 127 | 0.050 |
Why?
| | Risk Assessment | 1 | 2010 | 2976 | 0.050 |
Why?
| | Mental Status and Dementia Tests | 1 | 2020 | 21 | 0.050 |
Why?
| | Creatinine | 1 | 2022 | 425 | 0.040 |
Why?
| | Uric Acid | 1 | 2021 | 148 | 0.040 |
Why?
| | Parents | 1 | 2008 | 1189 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2008 | 3116 | 0.040 |
Why?
| | Overweight | 1 | 2023 | 474 | 0.040 |
Why?
| | Acute Disease | 1 | 2002 | 915 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2023 | 937 | 0.040 |
Why?
| | Memory | 1 | 2020 | 209 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1375 | 0.040 |
Why?
| | Amino Acids | 1 | 2022 | 451 | 0.040 |
Why?
| | Clinical Competence | 1 | 2005 | 899 | 0.040 |
Why?
| | International Cooperation | 1 | 2018 | 172 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 900 | 0.040 |
Why?
| | Patient Care Planning | 1 | 2018 | 139 | 0.040 |
Why?
| | Sex Factors | 1 | 2002 | 1721 | 0.030 |
Why?
| | Self Efficacy | 1 | 2018 | 355 | 0.030 |
Why?
| | Age Factors | 1 | 2002 | 2894 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 678 | 0.030 |
Why?
| | International Agencies | 1 | 2014 | 29 | 0.030 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2018 | 497 | 0.030 |
Why?
| | Mental Disorders | 1 | 2002 | 897 | 0.030 |
Why?
| | Societies, Scientific | 1 | 2014 | 47 | 0.030 |
Why?
| | Adolescent Medicine | 1 | 2014 | 33 | 0.030 |
Why?
| | Adult | 3 | 2013 | 30654 | 0.030 |
Why?
| | Drug Monitoring | 1 | 2014 | 184 | 0.030 |
Why?
| | Child Mortality | 1 | 2012 | 10 | 0.030 |
Why?
| | Exercise | 2 | 2014 | 1644 | 0.020 |
Why?
| | Brain | 1 | 2023 | 2379 | 0.020 |
Why?
| | Syndrome | 1 | 2012 | 337 | 0.020 |
Why?
| | Circadian Rhythm | 1 | 2014 | 354 | 0.020 |
Why?
| | Injury Severity Score | 1 | 2012 | 457 | 0.020 |
Why?
| | Risk | 1 | 2013 | 815 | 0.020 |
Why?
| | Trauma Centers | 1 | 2012 | 325 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1177 | 0.020 |
Why?
| | Speech Disorders | 1 | 2009 | 30 | 0.020 |
Why?
| | Glucagon | 1 | 2009 | 93 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3015 | 0.020 |
Why?
| | Hyperventilation | 1 | 2008 | 8 | 0.020 |
Why?
| | Mood Disorders | 1 | 2009 | 115 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 6141 | 0.020 |
Why?
| | Young Adult | 2 | 2014 | 10498 | 0.020 |
Why?
| | Vision Disorders | 1 | 2009 | 130 | 0.020 |
Why?
| | Osmolar Concentration | 1 | 2008 | 174 | 0.020 |
Why?
| | Magnesium | 1 | 2008 | 145 | 0.020 |
Why?
| | Hospitals, University | 1 | 2008 | 170 | 0.020 |
Why?
| | Respiration | 1 | 2008 | 182 | 0.020 |
Why?
| | Phosphates | 1 | 2008 | 159 | 0.020 |
Why?
| | Awareness | 1 | 2008 | 92 | 0.020 |
Why?
| | Eating | 1 | 2009 | 347 | 0.020 |
Why?
| | Age of Onset | 1 | 2008 | 449 | 0.020 |
Why?
| | Triglycerides | 1 | 2008 | 471 | 0.020 |
Why?
| | Cerebral Ventricles | 1 | 2006 | 47 | 0.020 |
Why?
| | Parent-Child Relations | 1 | 2008 | 234 | 0.020 |
Why?
| | Headache | 1 | 2006 | 132 | 0.020 |
Why?
| | Cardiology | 1 | 2005 | 259 | 0.010 |
Why?
| | Medicaid | 1 | 2005 | 409 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1715 | 0.010 |
Why?
|
|
Rewers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|